Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on palladium catalyzed Heck coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed route for bilastine intermediates ensures high yield and safety. Reliable supplier for pharmaceutical manufacturing cost reduction.
Patent CN102964334B details a novel Heck-reduction route for 2-thiopheneethanol, offering mild conditions and high purity for cardiovascular drug intermediates.
Advanced process for CNS drug intermediates via optimized Pd-coupling. Enhances yield and scalability for cost reduction in API manufacturing.
Patent CN102311381A details a high-purity Heck coupling method for Acrivastine precursors, offering superior selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN102503763A details a high-selectivity Heck reaction for stilbene synthesis. This method offers superior regioselectivity and yield for reliable pharmaceutical intermediates supply.
Patent CN103724239A reveals a high-yield two-step route for Belinostat intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101084197B discloses a novel Heck coupling process for Rosuvastatin intermediates, offering improved scalability and cost reduction in pharmaceutical manufacturing.
Patent CN109369353A details a palladium-catalyzed route for metoprolol intermediates offering significant cost reduction in pharma manufacturing and enhanced supply chain reliability for buyers.
Overcome synthesis challenges of trisubstituted allenes with mild reaction conditions, high functional group tolerance, and 70%+ yields. Reduce supply chain risks for API manufacturing.